Home › Funds › TRUST CO OF VERMONT › ABT

TRUST CO OF VERMONT position in ABT

Abbott Laboratories · Health Care

TRUST CO OF VERMONT reported holding 186,472 shares of ABT (Abbott Laboratories) in its Q3 2026 13F filing — a position valued at US$18.4M, representing 0.66% of its reported portfolio and ranking #41 among its reported holdings. TRUST CO OF VERMONT has disclosed ABT holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)186.47K sh
Reported value held$18.43M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How TRUST CO OF VERMONT's ABT position evolved

TRUST CO OF VERMONT first disclosed a stake in ABT in Q3 2023 at 187,829 shares (US$18.2M). The position peaked in Q2 2025 at 190,755 shares, worth US$25.9M. Across 12 filings, TRUST CO OF VERMONT increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 186,472 shares valued at US$18.4M — a reduction of -4,620 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 187.83K $18.19M New
Q4 2023 168.01K $18.49M Reduce
Q1 2024 200.94K $22.84M Add
Q3 2024 208.88K $23.81M Add
Q4 2024 199.28K $22.54M Reduce
Q1 2025 192.43K $25.53M Reduce
Q2 2025 190.75K $25.94M Reduce
Q3 2025 189.37K $25.36M Reduce
Q4 2025 187.40K $23.48M Reduce
Q1 2026 186.81K $19.18M Hold
Q2 2026 191.09K $17.34M Add
Q3 2026 186.47K $18.43M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (Abbott Laboratories) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has TRUST CO OF VERMONT held ABT?

TRUST CO OF VERMONT has disclosed ABT holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is TRUST CO OF VERMONT's current position in ABT?

As of Q3 2026, TRUST CO OF VERMONT holds 186.47K shares of ABT (Abbott Laboratories), valued at $18.43M, representing 0.66% of its reported portfolio and ranking #41.

Has TRUST CO OF VERMONT been buying or selling ABT?

In the latest 13F filing (Q3 2026), TRUST CO OF VERMONT reduced its position in ABT. The position peaked in Q2 2025 at 190.75K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.